https://covid-19.cochrane.org/studies/crs-13478000

NCT04368728
covid-19.cochrane.org

NCT04368728

A Phase 1/2, Placebo-Controlled, Randomized, Observer-Blind, Dose-Finding Study to Describe the Safety, Tolerability, Immunogenicity, and Potential Efficacy of SARS-COV-2 RNA Vaccine Candidates Against COVID-19 in Healthy Adults